retina

Browse articles from EyeWorld.org related to the retina. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

Read more about the article EyeWorld Weekly, April 18, 2025
EyeWorld Weekly

EyeWorld Weekly, April 18, 2025

➤ Positive results in Phase 1 trial for geographic atrophy cell-based therapy ➤ Enrollment complete for Phase 3 DME drop trials ➤ Enrollment complete in study for hydrogel retinal sealant ➤ First patient dosed in Phase 2 trial studying oral diabetic retinopathy therapy ➤ Regenerative Medicine Advanced Therapy designation granted to gene therapy candidate for X-linked retinoschisis ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, April 18, 2025
April 18, 2025
Read more about the article EyeWorld Weekly April 11, 2025
EyeWorld Weekly

EyeWorld Weekly April 11, 2025

➤ NDA submitted to the FDA for presbyopia drop ➤ FDA issues complete response letter to dry eye NDA ➤ FDA accepts BLA resubmission for bevacizumab to treat wet AMD ➤ One-month results in Phase 1/2 trial for treating Leber congenital amaurosis in a pediatric patient ➤ ASCRS news and events

Comments Off on EyeWorld Weekly April 11, 2025
April 11, 2025
Read more about the article EyeWorld Weekly, March 28, 2025
EyeWorld Weekly

EyeWorld Weekly, March 28, 2025

➤ Voluntary IOL recall ➤ Phase 4 study assesses patient-reported outcomes of dry eye drop ➤ Study: synthetic opsin restores vision in cases of severe retinal degeneration ➤ Phase 3 endpoints not met in trial evaluating wet AMD treatment ➤ Merger news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, March 28, 2025
March 28, 2025
Read more about the article EyeWorld Weekly, March 21, 2025
EyeWorld Weekly

EyeWorld Weekly, March 21, 2025

➤ Study: long-term efficacy of uveoscleral outflow enhancement for glaucoma ➤ FDA grants expanded indication for fluocinolone acetonide intravitreal implant ➤ First patient dosed in Phase 1/2 gene therapy trial targeting Stargardt disease ➤ Merger complete ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, March 21, 2025
March 21, 2025
Read more about the article EyeWorld Weekly, March 14, 2025
EyeWorld Weekly

EyeWorld Weekly, March 14, 2025

➤ FDA accepts new drug application for pharmaceutical aiming to treat pediatric myopia ➤ FDA approves treatment for macular telangiectasia type 2 ➤ Survey reveals perspectives of patients with glaucoma ➤ New wearable vision testing platform ➤ Seeking Fast Track Designation for investigational treatment of neuropathic corneal pain ➤ Fast Track Designation granted to gene therapy targeting X-linked retinoschisis ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, March 14, 2025
March 14, 2025
Read more about the article EyeWorld Weekly, February 28, 2025
EyeWorld Weekly

EyeWorld Weekly, February 28, 2025

➤ ASCRS EyeWorld Weekly: View the current issue ➤ Transepithelial crosslinking NDA submission accepted ➤ Fast Track designation granted to drop being investigated for night driving impairment due to visual disturbances ➤ First-in-human interventional study for gene therapy treating Leber congenital amaurosis 4 ➤ Positive outcomes observed for geographic atrophy drug ➤ Regenerative Medicine Advanced Therapy designation granted to stem cell therapy for dry AMD ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, February 28, 2025
February 28, 2025
Read more about the article EyeWorld Weekly, February 21, 2025
EyeWorld Weekly

EyeWorld Weekly, February 21, 2025

➤ FDA approves new viscoelastic system ➤ Expanded label approved for geographic atrophy treatment ➤ Biologics application accepted for aflibercept biosimilar ➤ Update on gene therapy program ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, February 21, 2025
February 21, 2025
Read more about the article EyeWorld Weekly, February 14, 2025
EyeWorld Weekly

EyeWorld Weekly, February 14, 2025

➤ ASCRS EyeWorld Weekly: View the current issue ➤ Study: COVID-19 significantly reduced rate of ophthalmic procedures ➤ New device provides non-surgical treatment for lower lid laxity ➤ Autonomous Diabetic Retinopathy Screening offers ‘unparalleled results’ ➤ 52-week data from Phase 2b study evaluating wet AMD therapy ➤ Subgroup analysis provides additional data on wet AMD therapy ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, February 14, 2025
February 14, 2025
Read more about the article EyeWorld Weekly, February 7, 2025
EyeWorld Weekly

EyeWorld Weekly, February 7, 2025

➤ FDA approves continuous delivery treatment for DME ➤ Positive topline data from Phase 2 trials for new glaucoma treatment ➤ Positive 6-month data from clinical trial evaluating drug delivery for treatment of DME ➤ Pivotal study evaluating AI algorithm for neovascular AMD with home OCT published ➤ Regenerative Medicine Advanced Therapy designation granted to X-linked retinitis pigmentosa treatment ➤ Promising results for ophthalmic gel to treat geographic atrophy ➤ Recruitment complete in trial for continuous range-of-vision IOL ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, February 7, 2025
February 7, 2025